Health And Medicine
-
Flu Tool guides patient decision-making
Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources. Read MoreAug 14, 2012
-
Key to a woman’s heart (condition)?
Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity. Read MoreAug 10, 2012
-
New therapeutic target for cold, flu viruses identified
Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells. Read MoreAug 9, 2012
-
Study links rare genetic marker to brain cancer
Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma. Read MoreAug 9, 2012
-
Team creates new view of body’s infection response
A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases. Read MoreAug 9, 2012
-
Network approach yields glioblastoma clues
MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor. Read MoreAug 9, 2012
-
Ancestry impacts smoking risk for lungs
Smoking is more detrimental to lung function in individuals with high proportions of African ancestry. Read MoreAug 7, 2012
-
Early HIV treatment also can prevent TB: study
Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease. Read MoreAug 2, 2012
-
Biomarkers may offer autism clues
A combination of biomarkers may reveal new clues about causes of and potential interventions for autism. Read MoreJul 31, 2012
-
National type I diabetes prevention trial now an option for younger children
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old. Read MoreJul 31, 2012
-
Study finds mutation in melanoma sensitive to drug
An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. Read MoreJul 26, 2012
-
On the hunt for bladder cancer factors
A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention. Read MoreJul 26, 2012
-
Proteins guard against cancer spread
Targeting immune system proteins may keep prostate cancer from spreading to bone. Read MoreJul 24, 2012
-
High consumption of vitamin E may lower liver cancer risk
iStock High consumption of vitamin E either from diet or vitamin supplements may lower the risk of liver cancer, according to a study published July 17 in the Journal of the National Cancer Institute. The study was conducted by investigators from the Shanghai Cancer Institute,… Read MoreJul 20, 2012
-
VU to map gaps in physician coverage across nation
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA). Read MoreJul 19, 2012
-
Study tracks medication-related problems after hospital discharge
As more and better treatments are developed for heart disease, it is becoming more difficult to safely manage care as patients return home from the hospital. A new study led by Vanderbilt researchers highlights growing concern that the period after hospital discharge is a risky time, especially for cardiac patients. Read MoreJul 19, 2012
-
Long antibodies better against HIV
Understanding how antibodies with long “loops” form may be important for HIV vaccine development. Read MoreJul 19, 2012
-
Insights for neuroscience drug discovery
When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects. Read MoreJul 17, 2012
-
Childhood cancer investigator lands ‘Lemonade Stand’ grant
Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer. Read MoreJul 12, 2012
-
VU leading international trial of new stroke therapy
Researchers at Vanderbilt University Medical Center are leading an international clinical trial to examine the functional benefits of a combined therapy to treat acute ischemic stroke. Read MoreJul 12, 2012